Cargando…

Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis

Interleukin (IL)-2 is expressed during T cell activation and induces the proliferation and differentiation of T cells. CD4(+)Foxp3(+) regulatory T cells (Tregs) constitutively express the high affinity IL-2 receptor (CD25/IL-2Rα) and rapidly respond to IL-2 to elaborate numerous suppressive mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abo, Hirohito, Flannigan, Kyle L., Geem, Duke, Ngo, Vu L., Harusato, Akihito, Denning, Timothy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428029/ https://www.ncbi.nlm.nih.gov/pubmed/30930900 http://dx.doi.org/10.3389/fimmu.2019.00459

Ejemplares similares

Harnessing Regulatory T Cells for the Treatment of Inflammatory Bowel Disease
por: Geem, Duke, et al.
Publicado: (2015)

Contribution of Mesenteric Lymph Nodes and GALT to the Intestinal Foxp3+ Regulatory T-Cell Compartment
por: Geem, Duke, et al.
Publicado: (2016)

IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria
por: Flannigan, Kyle L., et al.
Publicado: (2016)

IL-36γ signaling controls the induced regulatory T cell – T(H)9 cell balance via NFκB activation and STAT transcription factors
por: Harusato, Akihito, et al.
Publicado: (2017)

Epithelial Traffic Control: IL22 Gives TA Cells the Green Light
por: Abo, Hirohito, et al.
Publicado: (2018)

N-acetylglucosamine-6-O-sulfation on intestinal mucins prevents obesity and intestinal inflammation by regulating gut microbiota
por: Abo, Hirohito, et al.
Publicado: (2023)

Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3(+) Tregs
por: Chen, Xin, et al.
Publicado: (2021)

IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25(+)Foxp3(-) T cells
por: Tomala, Jakub, et al.
Publicado: (2021)

IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
por: Qu, Qiuxia, et al.
Publicado: (2020)

Erythroid differentiation regulator-1 induced by microbiota in early life drives intestinal stem cell proliferation and regeneration
por: Abo, Hirohito, et al.
Publicado: (2020)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
por: Menzella, Francesco, et al.
Publicado: (2015)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation
por: Jones, Mark B., et al.
Publicado: (2019)

IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection
por: Bézie, Séverine, et al.
Publicado: (2020)

The Cytokine Receptor IL-7Rα Impairs IL-2 Receptor Signaling and Constrains the In Vitro Differentiation of Foxp3(+) Treg Cells
por: Waickman, Adam T., et al.
Publicado: (2020)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Isolation of Immunocomplexes from Zebrafish Brain
por: Michel, Jennifer Carlisle, et al.
Publicado: (2023)

IL-35 promotes CD4(+)Foxp3(+) Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms
por: Shao, Ying, et al.
Publicado: (2021)

IL‐2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8(+) T cells
por: Zhou, Yu‐Xi, et al.
Publicado: (2018)

Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]
Publicado: (2021)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

The small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function
por: Prakhar, Praveen, et al.
Publicado: (2021)

Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R
por: Zhao, Jingxian, et al.
Publicado: (2012)

β-Cell–Specific IL-2 Therapy Increases Islet Foxp3(+)Treg and Suppresses Type 1 Diabetes in NOD Mice
por: Johnson, Mark C., et al.
Publicado: (2013)

Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD
por: Jin, Yang, et al.
Publicado: (2014)

Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3(+) Treg cell function in the intestine
por: Harrison, OJ, et al.
Publicado: (2015)

Protocol for acquiring samples to assess the impact of microplastics on immune microenvironments in the mouse intestine
por: Harusato, Akihito, et al.
Publicado: (2023)

Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3(+) Tregs in vitro
por: DeOca, Kayla B., et al.
Publicado: (2020)

The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)

CTLA-4 Modulates the Differentiation of Inducible Foxp3(+) Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
por: Verhagen, Johan, et al.
Publicado: (2014)

Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3(+) Treg Cells by Multiparameter Flow Cytometry
por: Li, Can, et al.
Publicado: (2020)

IL‐34 deficiency impairs FOXP3(+) Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis
por: Freuchet, Antoine, et al.
Publicado: (2022)

IL-33–mediated Eosinophilia Protects against Acute Lung Injury
por: Krishack, Paulette A., et al.
Publicado: (2021)

Natural Treg and role of IL-2 in lupus
por: Riemekasten, Gabriela, et al.
Publicado: (2011)

IL-2-based approaches to Treg enhancement
por: Harris, Ffion, et al.
Publicado: (2022)

Immunocomplexed Antigen Capture and Identification by Native Top-Down Mass Spectrometry
por: McGee, John P., et al.
Publicado: (2023)

Cellular tools for biosimilar mAb analysis
por: Lindemann, Carsten, et al.
Publicado: (2013)

Evolving trends in mAb production processes
por: Shukla, Abhinav A., et al.
Publicado: (2017)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Gschwend, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6akicr0jbh70l0p2617d1jgih